Iquifib

What Iquifib does

Iquifib (Instituto de Química y Fisicoquímica Biológicas Dr. Alejandro Paladini) is a non-profit scientific research institute affiliated with Argentina's CONICET (National Scientific and Technical Research Council) and the University of Buenos Aires, operating from two locations in Buenos Aires (Junín 956 and Paraguay 2155). The institute conducts fundamental research in biological chemistry and physicochemistry across approximately 20 specialized laboratory groups, with active programs in protein biochemistry and conformation, molecular biology, cellular signaling (including growth hormone and peptide hormone signal transduction), tumor biology (liver and mammary), lipid metabolism, neuroscience and neuroactive compound development, polymer chemistry, toxicology of heavy metals, and plant stress responses in wheat and barley. Methodologically, the institute employs specialized techniques such as photoactivatable and fluorescent probes for plasma membrane calcium ATPase (PMCA) studies, computational metabolic control analysis, and characterization of P1B-type copper ATPases using Archaeoglobus fulgidus as a model system.

The institute's customer base is academic rather than commercial: it serves graduate students, CONICET investigators, and UBA researchers, with end products being peer-style research output, trained researchers, and graduate-level courses (e.g., MECPI) plus a regular seminar series. The go-to-market model is therefore community-led and institutionally embedded rather than commercial, with research disseminated through academic publications, seminars, and collaborations within the CONICET network.

The business model is non-commercial. Operating support flows from public research funding via CONICET and UBA; there are no disclosed commercial pricing models, licensing fees, or royalties. The institute operates as a CONICET Ejecutora (Executing Unit) and is structurally integrated into UBA's Faculty of Pharmacy and Biochemistry, with many researchers holding dual UBA-CONICET appointments. External industry engagement is limited and transactional — notably a research collaboration receiving the BLZ945 inhibitor from Novartis for a multiple sclerosis microglial modulation study — which does not constitute a commercial revenue stream.

Name

Iquifib

Legal name

Instituto de Química y Fisicoquímica Biológicas Dr. Alejandro Paladini (IQUIFIB)

Website

https://iquifib.org

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Iquifib is a non-profit Argentine research institute affiliated with CONICET and the University of Buenos Aires, conducting fundamental research in biological chemistry and physicochemistry across 20 laboratory groups and training graduate researchers in Buenos Aires.

Ownership category

akta.pro rank

Product category

Academic Life Sciences Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Colleges, Universities, and Professional Schools (61131)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYEDAHAGAI

Biomedical Sciences & Medical Research Institutes (University-Based)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

Keywords

• Biological chemistry research
• Molecular biology studies
• Academic research institute
• Biochemistry laboratory
• Life sciences research

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Public research funding: Government-funded research institute supported by CONICET (National Scientific and Technical Research Council) and the University of Buenos Aires (UBA)

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Iquifib is a non-profit academic research institute that conducts scientific research in biological chemistry, molecular biology, and biochemistry. It hosts approximately 20 working groups and ~116 members, and is jointly affiliated with CONICET and the University of Buenos Aires. The institute also delivers academic courses and seminars.

Product overview

Iquifib (Instituto de Química y Fisicoquímica Biológicas - Conicet / UBA) is a scientific research institute affiliated with CONICET and the University of Buenos Aires. The institution does not offer commercial products or services; it conducts fundamental research in biochemistry, biophysics, and molecular biology through research groups focused on areas including protein biochemistry, signal transduction, molecular machines, tumor biology, and plant stress responses. The institute provides academic courses and seminars as part of its educational mission.

Differentiator

Problem solved

Functional benefit

Products and services

• Biological Chemistry and Molecular Biology Research Programs Multi-group fundamental scientific research programs in biological chemistry, molecular biology, and biochemistry, organized across approximately 20 working groups and serving the academic research community and graduate trainees.
• Academic Courses and Seminars Graduate-level academic training delivered on premises through courses and seminars in biological chemistry and related disciplines, primarily for university students and early-career researchers.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• CONICET (National Scientific and Technical Research Council)coreStrategic or Co-development PartnerIQUIFIB is an official research unit of CONICET, operating as a Ejecutora (Executing Unit) under the CONICET research framework. The institute receives institutional support and research funding through this national research council affiliation.
• Universidad de Buenos Aires (UBA) - Faculty of Pharmacy and BiochemistrycoreStrategic or Co-development PartnerThe institute is integrated into the Faculty of Pharmacy and Biochemistry at UBA, sharing facilities and academic programs with the university. Many researchers hold dual appointments as UBA faculty members.
• Institute Dr Alejandro PaladinicoreStrategic or Co-development PartnerIQUIFIB is housed within the Dr Alejandro Paladini Institute and shares physical facilities with the Cátedra de Química Biológica Patológica.
• Novartis (Laboratory)minorStrategic or Co-development PartnerThe Multiple Sclerosis research project received BLZ945 inhibitor from Novartis for experimental studies on microglial modulation and remyelination.

Scale indicators3 records

Expansion highlights4 records

Direct peers

• IIBBA-CONICET (Instituto de Investigaciones Biomédicas): Biomedical research institute under CONICET focused on cancer, signal transduction, and molecular biology. Comparable in being a CONICET biomedical research unit with overlapping research themes like tumor biology and signaling.
• INQUIMAE (UBA-CONICET): Instituto de Química, Física de los Materiales, Medio Ambiente y Energía, a CONICET-UBA executing unit conducting physical-chemical and biological research. Most direct comparable as a co-located CONICET-UBA research institute with similar scale and structure.
• CIQUIBIC (UNC-CONICET): Centro de Investigaciones en Química Biológica de Córdoba, a CONICET-UNC research unit in biological chemistry. Directly comparable as a CONICET-affiliated biological chemistry research institute with similar lab structure.
• IFIBYNE (UBA-CONICET): Instituto de Fisiología, Biología Molecular y Neurociencias, a CONICET-UBA research unit focused on molecular biology, physiology, and neuroscience. Highly comparable in mission, governance, and headcount range to IQUIFIB.
• Fundación Instituto Leloir: Private non-profit research institute in Buenos Aires affiliated with CONICET, conducting biomedical research in protein structure, molecular biology, and neuroscience. Comparable as a Buenos Aires-based, CONICET-affiliated biomedical research organization of similar scale.
• IBR-CONICET (Instituto de Biología Molecular y Celular de Rosario): CONICET research institute in Rosario focused on molecular and cellular biology, signal transduction, and structural biology. Comparable as a same-tier Argentine CONICET executing unit with overlapping biochemical and molecular biology research.
• IBIOBA (CONICET): Instituto de Investigación en Biomedicina de Buenos Aires, a CONICET-partnered biomedical research institute. Comparable as a CONICET-affiliated biomedical research organization in Argentina with similar scientific scope.
• INGEBI-CONICET: Instituto de Ingeniería Genética y Biología Molecular, a CONICET research institute focused on molecular biology and genetic engineering. Comparable as a CONICET biomedical research unit in the same city operating in overlapping disciplines.

Broad incumbents

• CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas): IQUIFIB's parent entity and the principal federal research council of Argentina. Comparable as the overarching institution that funds, governs, and aggregates all of IQUIFIB's peer research units.
• Universidad de Buenos Aires (UBA) - Faculty of Pharmacy and Biochemistry: Host faculty into which IQUIFIB is integrated, providing infrastructure, students, and dual faculty appointments. Comparable as the principal public university and the institutional host for IQUIFIB's research and training activities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/iquifib

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Iquifib